About AMR Action Fund
It operates as a HealthTech. AMR Action Fund offers products and services including Antimicrobial Resistance Investments.
- SectorsHealthcare
- Website amractionfund.com
- Social LinkedIn X
Products & Services of AMR Action Fund
AMR Action Fund offers a comprehensive portfolio of products and services, including Antimicrobial Resistance Investments.
Investments are made in antimicrobial resistance treatment development.
People of AMR Action Fund
10 people are tracked at AMR Action Fund (6 in leadership, 1 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Henry Skinner | Chief Executive Officer | Leadership |
Martin Heidecker | Chief Investment Officer | Leadership |
Deepali Patel | Director, International Policy | Leadership |
John Alter | Head of External Affairs | Leadership |
Jaclyn Levy | Director, U.S. Policy | Leadership |
Chris Sweeney | Communications Director | Leadership |
Bill Burns | Board Chair | Board & advisors |
Carly Levine | Senior Associate | Team |
Henni-Karoliina Ropponen | Venture Analyst | Team |
Isabella Santi | Venture Analyst | Team |
Complete people profiles for AMR Action Fund
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to AMR Action Fund
10 companies that operate in the same segment as AMR Action Fund (Microbiome Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Biosolutions and enzymes are developed for biotechnology applications across industries. | 2000 | Bags Sword, Denmark | – | – | – | |
Pendulum is focused on developing advanced probiotic solutions. | 2012 | San Francisco, California, United States | USD 109.5 M | – | 55 | |
Gut microbiome insights, analytics, tests, and therapeutics are provided. | 2019 | Singapore, Singapore | USD 10.5 M | USD 1.37 M | – | |
Microbiome-based therapeutics for skin conditions like eczema are developed. | 2014 | Farmington, United States | USD 37.4 M | – | 12 | |
Engineered microbes are developed as programmable therapeutics for metabolic disorders. | 2013 | Cambridge, Massachusetts, United States | USD 34.4 M | USD 8 K | 1 | |
Therapeutics for infectious and autoimmune diseases are developed. | 2010 | Cambridge, Massachusetts, United States | USD 470.49 M | – | 71 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Microbiome-based therapeutics for gut diseases are developed. | 2017 | Edinburgh, Scotland, United Kingdom | USD 72.96 M | – | 65 | |
The gut-brain axis is explored for therapeutic and nutritional innovations. | 2014 | New York, New York, United States | USD 479 M | – | 84 | |
Microbiome therapeutics are developed to address diverse diseases. | 2010 | Cambridge, Massachusetts, United States | USD 257.13 M | USD 789 K | 103 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AMR Action Fund
Investments are directed towards biotechnology companies developing treatments for life-threatening antimicrobial-resistant infections. Partnerships are built to foster a sustainable innovation ecosystem for ongoing treatment evolution. Advocacy is conducted for market reforms and policy solutions to enhance the valuation of lifesaving drugs in society. The focus is on addressing the global threat of antimicrobial resistance through strategic funding and collaboration in the healthcare sector.
AMR Action Fund offers Antimicrobial Resistance Investments.